Reduced circulating natural killer T cells and γ/δ T cells in patients with systemic sclerosis

Journal of Rheumatology

Volumn 32, Issue 2, 2005, Pages 283-286

  Riccieri, Valeria ^a,c   Parisi, Gilberto ^a   Spadaro, Antonio ^a   Scrivo, Rossana ^a   Barone, Francesca ^a   Moretti, Tiziana ^b   Bernardini, Graziella ^b   Strom, Roberto ^b   Taccari, Egisto ^a   Valesini, Guido ^a  

^a Cattedra di Reumatologia   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

Author keywords

T cells; Natural killer cells; Non MHC restricted cytotoxicity; Systemic sclerosis; T cells

Indexed keywords

CD4 ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOFLUORESCENCE; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

ADULT; AGED; DOWN-REGULATION; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 13444309109     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Seaman WE. Natural killer cells and natural killer T cells. Arthritis Rheum 2000;43:1204-17.
2. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004;22:817-90.
3. Brenner MB, McLean J, Dialynas DP, et al. Identification of putative second T-cell receptor. Nature 1986;322:145-9.
4. Kioda J, Rivas A, Engleman EG. Natural killer (NK) cytotoxic activity of allospecific T cell receptor-γ/δ+ T cell clones: distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity. J Immunol 1989;142:4161-8.
5. Riccieri V, Spadaro A, Parisi G, et al. Down-regulation of natural killer cells and of γ/δ T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity? Lupus 2000;9:333-7.
6. Frieri M, Angadi C, Paolano A, et al. Altered T cell subpopulations and lymphocytes expressing natural killer cell phenotypes in patients with progressive systemic sclerosis. J Allergy Clin Immunol 1991;87:773-9.
7. Holcombe R, Baethge B, Wolf R, Betzing W, Stewart R. Natural killer cells and γ/δ T cells in scleroderma: relationship to disease duration and anti-Scl-70 antibodies. Ann Rheum Dis 1995;54:69-72.
8. Dalkilic E, Dilek K, Gullulu M, et al. Lymphocyte phenotypes in systemic sclerosis. Ann Rheum Dis 1999;58:719-24.
9. Kojo S, Adachi Y, Keino H, Taniguchi M, Sumida T. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum 2001;44:1127-38.
10. Gerli R, Agea E, Berlotto A, et al. Analysis of T cells bearing different isotypic forms of the γ/δ cell receptor in patients with systemic autoimmune diseases. J Rheumatol 1991;18:1504-10.
11. Giacomelli R, Matucci-Cerinic M, Cipriani P, et al. Circulating Vδ1+ T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis Rheum 1998;41:327-34.
12. Masi AT, Rodnan GP, Medsger TA Jr, et al. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
13. Steen VD, Powell DL, Medsger TA Jr. Clinical correlation and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
14. Reichert T, De Bruyere M, Deneys V, et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopathol 1991;60:190-208.
15. Gustafsson R, Totterman TH, Klareskog L, Hallgren R. Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis. Ann Rheum Dis 1990;49:40-5.
16. Dastot H, Schmid M, Gontier C, et al. Correlation between T cell receptor γ/δ isotypic forms and cytotoxic activity with human T cell clones and lines. Cell Immunol 1990;125:315-25.